Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
Akcea Therapeutics is a development and commercialization company focused on helping patients living with serious cardiometabolic lipid disorders.
Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering.
Juniper Pharmaceuticals is developing therapeutics that address unmet medical needs in women’s health.
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Intarcia Therapeutics is a biopharmaceutical company developing innovative therapies for chronic diseases.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics.
Rodin Therapeutics is discovering and developing first in class therapeutics for neurological disorders, applying unique insights into the role of epigenetics and novel chemical strategies to target specific HDAC complexes.
Cerevance is a new pharmaceutical company focused on central nervous system diseases.
Vyome Biosciences is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens.